Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Randomized evaluation of fibrinogen versus placebo in complex cardiovascular surgery: post hoc analysis and interpretation of phase III results.

Rahe-Meyer N, Levy JH, Mazer CD, Schramko A, Klein AA, Brat R, Okita Y, Ueda Y, Schmidt DS, Gill R.

Interact Cardiovasc Thorac Surg. 2019 Apr 1;28(4):566-574. doi: 10.1093/icvts/ivy302.

PMID:
30462259
2.

Randomized evaluation of fibrinogen vs placebo in complex cardiovascular surgery (REPLACE): a double-blind phase III study of haemostatic therapy.

Rahe-Meyer N, Levy JH, Mazer CD, Schramko A, Klein AA, Brat R, Okita Y, Ueda Y, Schmidt DS, Ranganath R, Gill R.

Br J Anaesth. 2016 Jul;117(1):41-51. doi: 10.1093/bja/aew169.

3.

Immune Responses in U.S. Military Personnel Who Received Meningococcal Conjugate Vaccine (MenACWY) Concomitantly with Other Vaccines Were Higher than in Personnel Who Received MenACWY Alone.

Broderick MP, Romero-Steiner S, Rajam G, Johnson SE, Milton A, Kim E, Choi LJ, Radin JM, Schmidt DS, Carlone GM, Messonnier N, Faix DJ.

Clin Vaccine Immunol. 2016 Aug 5;23(8):672-80. doi: 10.1128/CVI.00267-16. Print 2016 Aug.

4.

Naturally acquired antibodies against Haemophilus influenzae type a in Aboriginal adults, Canada.

Nix EB, Williams K, Cox AD, St Michael F, Romero-Steiner S, Schmidt DS, McCready WG, Ulanova M.

Emerg Infect Dis. 2015 Feb;21(2):273-9. doi: 10.3201/eid2102.140722.

5.

Persistence of serogroup C antibody responses following quadrivalent meningococcal conjugate vaccination in United States military personnel.

Patel M, Romero-Steiner S, Broderick MP, Thomas CG, Plikaytis BD, Schmidt DS, Johnson SE, Milton AS, Carlone GM, Clark TA, Messonnier NE, Cohn AC, Faix DJ.

Vaccine. 2014 Jun 24;32(30):3805-9. doi: 10.1016/j.vaccine.2014.05.001. Epub 2014 May 14.

6.

Molecular signatures of antibody responses derived from a systems biology study of five human vaccines.

Li S, Rouphael N, Duraisingham S, Romero-Steiner S, Presnell S, Davis C, Schmidt DS, Johnson SE, Milton A, Rajam G, Kasturi S, Carlone GM, Quinn C, Chaussabel D, Palucka AK, Mulligan MJ, Ahmed R, Stephens DS, Nakaya HI, Pulendran B.

Nat Immunol. 2014 Feb;15(2):195-204. doi: 10.1038/ni.2789. Epub 2013 Dec 15.

7.

Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trial.

Rahe-Meyer N, Hanke A, Schmidt DS, Hagl C, Pichlmaier M.

J Thorac Cardiovasc Surg. 2013 Mar;145(3 Suppl):S178-85. doi: 10.1016/j.jtcvs.2012.12.083.

8.

Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial.

Rahe-Meyer N, Solomon C, Hanke A, Schmidt DS, Knoerzer D, Hochleitner G, Sørensen B, Hagl C, Pichlmaier M.

Anesthesiology. 2013 Jan;118(1):40-50. doi: 10.1097/ALN.0b013e3182715d4d. Erratum in: Anesthesiology. 2013 May;118(5):1244.

PMID:
23249928
9.

Measurement of Haemophilus influenzae type a capsular polysaccharide antibodies in cord blood sera.

Schmidt DS, Bieging KT, Gomez-de-León P, Villaseñor-Sierra A, Inostroza J, Robbins JB, Schneerson R, Carlone GM, Romero-Steiner S.

Pediatr Infect Dis J. 2012 Aug;31(8):876-8. doi: 10.1097/INF.0b013e31825ab166.

10.

Validation and long term performance characteristics of a quantitative enzyme linked immunosorbent assay (ELISA) for human anti-PA IgG.

Semenova VA, Schiffer J, Steward-Clark E, Soroka S, Schmidt DS, Brawner MM, Lyde F, Thompson R, Brown N, Foster L, Fox S, Patel N, Freeman AE, Quinn CP.

J Immunol Methods. 2012 Feb 28;376(1-2):97-107. doi: 10.1016/j.jim.2011.12.002. Epub 2011 Dec 17.

PMID:
22197974
11.

Efficacy and safety of subcutaneous vivaglobin® replacement therapy in previously untreated patients with primary immunodeficiency: a prospective, multicenter study.

Borte M, Quinti I, Soresina A, Fernández-Cruz E, Ritchie B, Schmidt DS, McCusker C.

J Clin Immunol. 2011 Dec;31(6):952-61. doi: 10.1007/s10875-011-9588-5. Epub 2011 Sep 20.

PMID:
21932110
12.

A smooth transition protocol for patients with multifocal motor neuropathy going from intravenous to subcutaneous immunoglobulin therapy: an open-label proof-of-concept study.

Misbah SA, Baumann A, Fazio R, Dacci P, Schmidt DS, Burton J, Sturzenegger M.

J Peripher Nerv Syst. 2011 Jun;16(2):92-7. doi: 10.1111/j.1529-8027.2011.00330.x.

PMID:
21692906
13.

Evaluation of serum bactericidal antibody assays for Haemophilus influenzae serotype a.

Rouphael NG, Satola S, Farley MM, Rudolph K, Schmidt DS, Gomez-de-León P, Robbins JB, Schneerson R, Carlone GM, Romero-Steiner S.

Clin Vaccine Immunol. 2011 Feb;18(2):243-7. doi: 10.1128/CVI.00219-10. Epub 2010 Dec 22.

14.

Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization.

Li H, Soroka SD, Taylor TH Jr, Stamey KL, Stinson KW, Freeman AE, Abramson DR, Desai R, Cronin LX, Oxford JW, Caba J, Pleatman C, Pathak S, Schmidt DS, Semenova VA, Martin SK, Wilkins PP, Quinn CP.

J Immunol Methods. 2008 Apr 20;333(1-2):89-106. doi: 10.1016/j.jim.2008.01.007. Epub 2008 Feb 8.

PMID:
18304568
15.

Obesity-survival paradox-still a controversy?

Schmidt DS, Salahudeen AK.

Semin Dial. 2007 Nov-Dec;20(6):486-92. Review.

PMID:
17991192
16.

Impact of the rpoS genotype for acid resistance patterns of pathogenic and probiotic Escherichia coli.

Coldewey SM, Hartmann M, Schmidt DS, Engelking U, Ukena SN, Gunzer F.

BMC Microbiol. 2007 Mar 26;7:21.

17.

Analysis of anti-protective antigen IgG subclass distribution in recipients of anthrax vaccine adsorbed (AVA) and patients with cutaneous and inhalation anthrax.

Semenova VA, Schmidt DS, Taylor TH Jr, Li H, Steward-Clark E, Soroka SD, Ballard MM, Quinn CP.

Vaccine. 2007 Feb 26;25(10):1780-8. Epub 2006 Nov 27.

PMID:
17229495
18.

The cell-cell adhesion molecule EpCAM interacts directly with the tight junction protein claudin-7.

Ladwein M, Pape UF, Schmidt DS, Schnölzer M, Fiedler S, Langbein L, Franke WW, Moldenhauer G, Zöller M.

Exp Cell Res. 2005 Oct 1;309(2):345-57.

PMID:
16054130
19.

Mass value assignment of total and subclass immunoglobulin G in a human standard anthrax reference serum.

Semenova VA, Steward-Clark E, Stamey KL, Taylor TH Jr, Schmidt DS, Martin SK, Marano N, Quinn CP.

Clin Diagn Lab Immunol. 2004 Sep;11(5):919-23.

20.

Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax.

Quinn CP, Dull PM, Semenova V, Li H, Crotty S, Taylor TH, Steward-Clark E, Stamey KL, Schmidt DS, Stinson KW, Freeman AE, Elie CM, Martin SK, Greene C, Aubert RD, Glidewell J, Perkins BA, Ahmed R, Stephens DS.

J Infect Dis. 2004 Oct 1;190(7):1228-36. Epub 2004 Aug 30.

PMID:
15346332
21.

CD44 variant isoforms associate with tetraspanins and EpCAM.

Schmidt DS, Klingbeil P, Schnölzer M, Zöller M.

Exp Cell Res. 2004 Jul 15;297(2):329-47.

PMID:
15212938
22.

The association of the tetraspanin D6.1A with the alpha6beta4 integrin supports cell motility and liver metastasis formation.

Herlevsen M, Schmidt DS, Miyazaki K, Zöller M.

J Cell Sci. 2003 Nov 1;116(Pt 21):4373-90. Epub 2003 Sep 16.

23.

Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen.

Quinn CP, Semenova VA, Elie CM, Romero-Steiner S, Greene C, Li H, Stamey K, Steward-Clark E, Schmidt DS, Mothershed E, Pruckler J, Schwartz S, Benson RF, Helsel LO, Holder PF, Johnson SE, Kellum M, Messmer T, Thacker WL, Besser L, Plikaytis BD, Taylor TH Jr, Freeman AE, Wallace KJ, Dull P, Sejvar J, Bruce E, Moreno R, Schuchat A, Lingappa JR, Martin SK, Walls J, Bronsdon M, Carlone GM, Bajani-Ari M, Ashford DA, Stephens DS, Perkins BA.

Emerg Infect Dis. 2002 Oct;8(10):1103-10.

24.
25.

Assessment of chemoreflex sensitivity in free breathing young subjects by correction for respiratory influence.

Schmidt HB, Rauchhaus M, Francis DP, Davies CL, Nuding S, Peschel T, Schmidt DS, Coats AJ, Opitz H, Werdan K.

Int J Cardiol. 2001 Apr;78(2):157-65.

PMID:
11334660
26.

Adolescents with ASCUS: are they a high risk group?

Arora CD, Schmidt DS, Rader AE, Abdul-Karim F, Lazebnik R.

Clin Pediatr (Phila). 2001 Mar;40(3):133-8. Review.

PMID:
11307958
28.

CD44 variant isoforms on blood leukocytes in chronic inflammatory bowel disease and other systemic autoimmune diseases.

Wittig B, Seiter S, Schmidt DS, Zuber M, Neurath M, Zöller M.

Lab Invest. 1999 Jun;79(6):747-59.

PMID:
10378517
29.

Dissemination of lymphocytic choriomeningitis virus from the gastric mucosa requires G protein-coupled signaling.

Yin C, Djavani M, Schenkel AR, Schmidt DS, Pauza CD, Salvato MS.

J Virol. 1998 Nov;72(11):8613-9.

30.

Effects of oil-soluble organosulfur compounds from garlic on doxorubicin-induced lipid peroxidation.

Dwivedi C, John LM, Schmidt DS, Engineer FN.

Anticancer Drugs. 1998 Mar;9(3):291-4.

PMID:
9625441
32.

The role of the immune system in establishment of herpes simplex virus latency--studies using CD4+ T-cell depleted mice.

Schmidt DS, Eis-Hübinger AM, Schneweis KE.

Arch Virol. 1993;133(1-2):179-87.

PMID:
8240008
33.

Severity of leprosy eye lesions in armadillos infected with Mycobacterium leprae.

Brandt F, Zhou HM, Shi ZR, Kadzda J, Dhople AM, Kolk A, Schmidt DS.

Lepr Rev. 1990 Jun;61(2):188-92. No abstract available.

PMID:
2198417
34.

The pathology of the eye in armadillos experimentally infected with Mycobacterium leprae.

Brandt F, Zhou HM, Shi ZR, Kadzda J, Dhople AM, Kolk A, Schmidt DS.

Lepr Rev. 1990 Jun;61(2):112-31. Review.

PMID:
2198412
35.
36.

Control of the tRNA-tufB operon in Escherichia coli. 1. rRNA gene dosage effects and growth-rate-dependent regulation.

Van Delft JH, Verbeek HM, De Jong PJ, Schmidt DS, Talens A, Bosch L.

Eur J Biochem. 1988 Aug 1;175(2):355-62.

37.

Transcription of the tRNA-tufB operon of Escherichia coli: activation, termination and antitermination.

van Delft JH, Mariñon B, Schmidt DS, Bosch L.

Nucleic Acids Res. 1987 Nov 25;15(22):9515-30.

38.

The tRNA-tufB operon transcription termination and processing upstream from tufB.

Van Delft JH, Schmidt DS, Bosch L.

J Mol Biol. 1987 Oct 20;197(4):647-57.

PMID:
2448475
39.

[Sudden death of a young athlete].

Dietz A, Schmidt DS.

MMW Munch Med Wochenschr. 1981 Sep 25;123(39):1463-5. German. No abstract available.

PMID:
6456410
40.

[Mitochondrial antibodies in liver diseases].

Schmidt G, Kienle J, Schmidt DS, Wolf H, Wildhirt E.

Med Welt. 1979 Apr 6;30(14):518-21. German. No abstract available.

PMID:
372728
41.

[Liver diseases with microsomal antibodies. Frequency, clinical and immunological findings and course observations (author's transl)].

Schmidt G, Kienle J, Schmidt DS, Wolf H.

Z Gastroenterol. 1978 Aug;16(8):512-20. German.

PMID:
685348
42.

[Aneurism of ductus arteriosus Botalli in a newborn (author's transl)].

Kerstan J, Schmidt DS.

Monatsschr Kinderheilkd. 1977 Oct;125(10):888-91. German.

PMID:
917027
43.

[Frequency of chronic non-suppurative destructive cholangitis and primary biliary cirrhosis in comparison with other chronic inflammatory liver diseases].

Schmidt G, Kienle J, Schmidt DS, Brunner G.

Dtsch Med Wochenschr. 1976 Apr 30;101(18):693-6. German.

PMID:
1261400
44.

[Incidence of gallbladder complications in chronic inflammatory liver diseases].

Selmair H, Schmidt DS.

Z Gastroenterol. 1971;9(2):79-86. German. No abstract available.

PMID:
4277211
45.

[Enzyme histochemical studies on the pineal gland of normal and pregnant guinea pigs].

Vollrath L, Schmidt DS.

Histochemie. 1969;20(4):328-37. German. No abstract available.

PMID:
4391540

Supplemental Content

Loading ...
Support Center